WaFd (NASDAQ:WAFD), the parent company of Washington Federal Savings Bank, reported fiscal first-quarter net income of $64.2 million on Thursday, reflecting a resilient performance in a tightening credit environment.
Chevron (NYSE:CVX) and its joint-venture partners announced a major breakthrough in Eastern Mediterranean energy on Friday, reaching a Final Investment Decision (FID) to expand the production capacity of the Leviathan natural gas field.
President Donald Trump formalized a high-stakes "tax-and-trade" strategy for the semiconductor industry on Wednesday, signing a proclamation that imposes a 25% ad valorem tariff on high-performance AI chips produced abroad that transit through the U.S. before being exported to international customers.
First Majestic Silver Corp. (NYSE:AG) reported on Thursday that 2025 was a "transformational" year for the company, highlighted by record-breaking silver output and the successful multi-billion dollar integration of Gatos Silver.
Aduro Clean Technologies (NASDAQ:ADUR), a pioneer in water-based chemical recycling, announced its interim financial results for the second quarter of fiscal 2026 on Thursday.
B&G Foods (NYSE:BGS) announced Thursday that it has entered into a definitive agreement to acquire the broth and stock business of Del Monte Foods Corporation II for approximately $110 million in cash.
Axsome Therapeutics (NASDAQ:AXSM) announced on Thursday that it has dosed the first patient in its FORWARD Phase 3 clinical trial, a pivotal step in the development of AXS-14 (esreboxetine) for the management of fibromyalgia.
Clearway Energy Group (NYSE:CWEN) announced on Thursday that it has entered into three long-term power purchase agreements (PPAs) with Google, totaling 1.17 GW of carbon-free energy.
Neurocrine Biosciences (NASDAQ:NBIX) presented the first head-to-head imaging data on Thursday comparing the brain-binding potency of the two leading treatments for involuntary movement disorders.
Hoth Therapeutics (NASDAQ:HOTH) announced Thursday that it has received a positive regulatory conclusion under the European Union Clinical Trials Information System (CTIS) for Part I of its HT-001 clinical program.
The Allstate Corporation (NYSE:ALL) reported on Thursday that it incurred an estimated $80 million in pre-tax catastrophe losses for December 2025, or $64 million after-tax.
Bank of America has cautioned lawmakers that stablecoin rules could trigger a major shift in US bank deposits.
-640x358.jpg&w=3840&q=75)